• Home
  • About Us
    • About Us
    • Leadership Team
  • Science
    • Biologics
    • Biomanufacturing
    • Pipeline
  • Investors
    • Overview
    • SEC Filings
    • Press Releases
    • Presentations
    • Corporate Governance
    • Investor Resources
      semaglutide
      • Email Alerts
      • FAQs
      • Tax Documents
  • Careers
  • Contact Us

FDA Expands Indication of Use for Tivic Health’s ClearUP Sinus Pain Relief to Include Congestion for Common Cold, Flu and Allergies

Mar 24, 2021 | Press Releases

Helping Millions Through Bioelectronics Without MedicationSAN FRANCISCO, March 24, 2021 — Tivic Health® Systems Inc., a first-in-class developer of bioelectronics health devices, today announced that the U.S. Food and Drug Administration (FDA) has expanded...

Michael B. Foggs, M.D., Joins Tivic Health’s Medical Advisory Board

Nov 17, 2020 | Press Releases

SAN FRANCISCO, Nov. 17, 2020 — Tivic Health® Systems Inc., today announced that Michael B. Foggs, MD, FAAAAI, DFACAAI, FCCP, and chief of allergy and immunology at Advocate Medical Group of AdvocateAuroraHealth in Chicago has joined the company’s...

Michael B. Foggs, M.D., Joins Tivic Health’s Medical Advisory Board

Nov 17, 2020 | Press Releases

SAN FRANCISCO, Nov. 17, 2020 — Tivic Health® Systems Inc., today announced that Michael B. Foggs, MD, FAAAAI, DFACAAI, FCCP, and chief of allergy and immunology at Advocate Medical Group of AdvocateAuroraHealth in Chicago has joined the company’s...

Tivic Health Announces Issuance of Four Patents for ClearUP Sinus Pain Relief

Sep 29, 2020 | Press Releases

Patents Cover ClearUP’s Interface, Device and Features For Comfort, Effectiveness, ErgonomicsSAN FRANCISCO, Sept. 29, 2020 — Tivic Health® Systems Inc., a leading bioelectronics medical device company, today announced that the U.S. Patent and...

Tivic Health Announces Issuance of Four Patents for ClearUP Sinus Pain Relief

Sep 29, 2020 | Press Releases

Patents Cover ClearUP’s Interface, Device and Features For Comfort, Effectiveness, ErgonomicsSAN FRANCISCO, Sept. 29, 2020 — Tivic Health® Systems Inc., a leading bioelectronics medical device company, today announced that the U.S. Patent and...
« Older Entries
Next Entries »

Recent Posts

  • Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
  • Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
  • Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird’s National Security Conference
  • Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results
  • Valion Bio Announces Positive Safety Results From U.S. Government-Funded Entolimod Study, Paving Way For Therapeutic Efficacy Evaluation

Recent Comments

No comments to show.
©2026 Valion Bio

Privacy Policy

For ClearUP customer questions regarding warranty or other device inquiries, please reach out to customerservice@tivichealth.com.